Evidence map›Paper›PMID 33390469›Full record

ArticleInternal medicine (Tokyo, Japan)2021

Two Cases of Severe COVID-19 Pneumonia Effectively Treated with Extracorporeal Membrane Oxygenation in Addition to Favipiravir and Corticosteroid.

Masahiro Shinoda, Kenichi Kamachi, Shinichiro Ota, Lynn Yoshimatsu, Ryuichi Boku, Yuto Yoshida, Takatomo Hirouchi, Kanako Shinada, Takashi Sato, Miwa Morikawa and 3 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 26 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Masahiro ShinodaDepartment of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan.
Kenichi KamachiDepartment of Surgery, Tokyo Shinagawa Hospital, Japan.
Shinichiro OtaDepartment of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan.
Lynn YoshimatsuDepartment of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan.
Ryuichi BokuDepartment of Emergency Medicine, Tokyo Shinagawa Hospital, Japan.
Yuto YoshidaDepartment of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan.
Takatomo HirouchiDepartment of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan.
Kanako ShinadaDepartment of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan.
Takashi SatoDepartment of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan.
Miwa MorikawaDepartment of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan.
Koki IwataDepartment of Emergency Medicine, Tokyo Shinagawa Hospital, Japan.
Takashi MatsumotoDepartment of Cardiology, Tokyo Shinagawa Hospital, Japan.
Masaharu ShinkaiDepartment of Respiratory Medicine, Tokyo Shinagawa Hospital, Japan.
New Tokyo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Case 1: A 65-year-old man with novel coronavirus infection (COVID-19) complicated with acute respiratory failure. On admission, the patient was started on favipiravir and corticosteroid. However, due to a lack of significant improvement, he was introduced to mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Although iliopsoas hematoma occurred as a complication, the patient recovered. Case 2: A 49-year-old man with COVID-19 had been started on favipiravir and corticosteroid. Due to progressive respiratory failure, the patient underwent mechanical ventilation and ECMO. The patient recovered without complications. We successfully treated these severe cases with a multimodal combination of pharmacological and non-pharmacological supportive therapy.

Indexed as

Extracorporeal Membrane OxygenationRespiration, ArtificialAdrenal Cortex HormonesAgedAmidesAntiviral AgentsCOVID-19HumansMaleMethylprednisoloneMiddle AgedPyrazinesRespiratory InsufficiencySARS-CoV-2Adrenal Cortex HormonesAmidesAntiviral AgentsfavipiravirMethylprednisolonePyrazinescorticosteroidCOVID-19extracorporeal membrane oxygenationfavipiravirmechanical ventilation

Identifiers

PMID33390469
PMCPMC7835466
OpenAlexW3120557430

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.